CD8A and hepatocellular carcinoma: Therapeutic modulation of the gut microbiota using antibiotics, probiotics, prebiotics and FMT emerges as a novel strategy for preventing the development of chronic hepatitis into HCC and for treating HCC,250 providing valuable supplementation for CD8+ T cell‐based immunotherapy.